Latest News

Model shows cancer’s birth and spread from single cell

The discovery – reported in a Science paper – could change the way we understand melanoma and other cancers, and could lead to drugs that prevent cancer by blocking the genes that trigger this key event. It resolves a mystery that has been puzzling cancer researchers: why some cells in the body carry gene mutations […]

Read More

Coming ever closer – first PARP inhibitor licensed in Europe

Designed to target cancers in people carrying inherited faults in the BRCA1 or BRCA2 genes, PARP inhibitors have been tested in clinical trials for patients with breast, ovarian and prostate cancer caused by these genetic flaws. However, the journey from the lab to the clinic has been far from smooth, and the results have been […]

Read More